SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CLTR COULTER PHARMACEUTICAL
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
666 17 0 CLTR
Emcee:  HARRY GIBSON Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
641What a shame a year was lost. Wednesday November 1, 5:00 pm Eastern Time Press keokalani'nui-11/1/2000
640Blood, 1 November 2000, Vol. 96, No. 9, pp. 2934-2942 PLENARY PAPER A phase I/Biomaven-10/30/2000
639Hebrew. ZeevZeev Hed-10/29/2000
638Zeev, which languages. V1Vector1-10/29/2000
637Just a few weeks until we find out whether the BLA was accepted. V1Vector1-10/29/2000
636I am sorry, but I could not stop laughing, someone actually called his new produZeev Hed-10/28/2000
635spread is narrowing: siliconinvestor.comtom pope-10/26/2000
634Thanks for that link. Someone just posted it on the Yahoo board and I read it thberblady-10/23/2000
633Berblady, excellent points all. I am pressed for time now, but this, which I haPseudo Biologist-10/23/2000
632Many thanks for your enthusiastic welcome. Thanks also for the link to that artberblady-10/23/2000
631>> why lighten up? << Because the risk-reward ratio has changed. TRCMac-10/23/2000
630<b>The</b> berblady? Wow, well, welcome aboard. As you sure know, Pseudo Biologist-10/23/2000
629Larry - I think you've got it exactly right.berblady-10/22/2000
628<<The Food & Drug Administration is expected to approve Bexxar in Novelrb-10/22/2000
627Steven Gillis: In the Pink at Corixa [BW] In the death-defying world of biotechsim1-10/22/2000
626<<I’ve been lightening up, although I’ll keep a few shares, since it seemsVector1-10/21/2000
625>> Since the closing date of the acquisition is after the "FDA acceptRCMac-10/20/2000
624Boy, this is a tough one. If Bexxar makes it, you make up the current discount Atom pope-10/20/2000
623Switching now gives up the $5 premium between CLTR and CRXA, so there's no fBiomaven-10/20/2000
622My initial read on this is you indeed remove the Bexxar approval risk by switchiLighthouse-10/20/2000
621I was thinking the same thing. Would it make sense to switch my CLTR shares forHoward Bennett-10/20/2000
620I am still scratching my head over this deal. What is the incentive to continue Lighthouse-10/20/2000
619Corixa to buy Coulter for over $900 mln in stock NEW YORK, Oct 16 (Reuters) - BiHoward Bennett-10/16/2000
618Coulter Pharmaceutical and SmithKline Beecham Announce Priority Review Status foHoward Bennett-10/5/2000
617Detail from Coulter - Oct. 3, 2000-- Coulter Pharmaceutical, Inc. (Nasdaq:CLTR -nigel bates-10/3/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News